-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Biomechanical assessment of the reconstruction of the anterolateral ligament during anterior cruciate ligament surgery
Martin Komzak, Radek Hart, Libor Pasa, Petr Smid, David Nahlik, Tomas Pavlik
Research Paper: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Arformoterol: rationale for use in chronic obstructive pulmonary disease
Jordan Terasaki, Shawn PE Nishi, Bill T Ameredes & Gulshan Sharm
Review: Clinical Trail Outcomes: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Skeletal muscle as an emerging therapeutic target in spinal and bulbar muscular atrophy
Soraru Gianni
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Development of a cross-pharmaceutical database: a paradigm change for accelerating the drug-development process
Larry Alphsclinical trials , database , drug development ,neuropsychiatric ,pharmaceutical
Editorial: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Emerging therapies for pulmonary arterial hypertension: a review of recently completed and ongoing clinical trials
Amresh Raina, Raymond L Benza
Review: Clinical Trail Outcomes: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation
-
Gender differences and clinical trial design
Sabine Oertelt-Prigione
Editorial: Clinical Investigation